Pathway to success in Regulatory filings
Boost your Knowledge
Lonza Regulatory Services - Small Molecules
Today timelines for drug development are getting shorter and shorter with 40% of approvals...
Navigating CMC Regulatory Requirements For Accelerated Commercialization
An increasing number of therapies obtain designations with accelerated and priority reviews. The...
24 May 2022
Lonza and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics and Small...
9 May 2022
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech...
31 Mar 2022
Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation...
21 Mar 2022
Oasmia Signs Manufacturing Agreement with Lonza for Ovarian Cancer Drug Candidate Cantrixil
18 Jan 2022